
Public health and research
The first CRISPR medicine
The UK approved Casgevy, a treatment that edits a patient's own blood stem cells with CRISPR to treat sickle cell disease and beta-thalassaemia. It followed the gene-editing work of Emmanuelle Charpentier and Jennifer Doudna.
Why it matters
It is the first approved medicine to use gene editing, aimed at diseases that mostly affect people in Africa and India.
For patients
Sickle cell patients faced lifelong pain crises; in trials most were free of them after one treatment.
People: Emmanuelle Charpentier, Jennifer Doudna
Builds on: The human genome read